QQ客服 官方微博 反馈留言

	QSAR studies of aminopeptidase N/CD13 (APN) inhibitors with the scaffold 3-phenylpropane-1,2-diamine and molecular docking
	Xu, Yingying; Zhang, Lei; Li, Minyong; Xu, Wenfang; Fang, Hao; Shang, Luqing
刊名	MEDICINAL CHEMISTRY RESEARCH
	2012
卷号	21期号:7页码:1000-1015
关键词	APN inhibitor Antitumor 3-D QSAR CoMFA CoMSIA Docking
DOI	10.1007/s00044-011-9597-1
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5201858
专题	山东大学
作者单位	Shandong Univ, Dept Med Chem, Sch Pharm, Jinan 250012, Shandong, People
推荐引用方式 GB/T 7714	Xu, Yingying,Zhang, Lei,Li, Minyong,et al. QSAR studies of aminopeptidase N/CD13 (APN) inhibitors with the scaffold 3-phenylpropane-1,2-diamine and molecular docking[J]. MEDICINAL CHEMISTRY RESEARCH,2012,21(7):1000-1015.
APA	Xu, Yingying,Zhang, Lei,Li, Minyong,Xu, Wenfang,Fang, Hao,&Shang, Luqing.(2012).QSAR studies of aminopeptidase N/CD13 (APN) inhibitors with the scaffold 3-phenylpropane-1,2-diamine and molecular docking.MEDICINAL CHEMISTRY RESEARCH,21(7),1000-1015.
MLA	Xu, Yingying,et al."QSAR studies of aminopeptidase N/CD13 (APN) inhibitors with the scaffold 3-phenylpropane-1,2-diamine and molecular docking".MEDICINAL CHEMISTRY RESEARCH 21.7(2012):1000-1015.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。